APA (7th ed.) Citation

Hassoun, M. M., Mahfoud, Z. R., Istambouli, R., Mansour, A. M., Salti, H., Allam, S., . . . Hamam, R. N. (2026). Intravitreal versus Subcutaneous Adalimumab in Active Non-Infectious Uveitis: A Randomized Non-Inferiority Trial. Ocular Immunology & Inflammation, 34(1), 1. https://doi.org/10.1080/09273948.2025.2526692

Chicago Style (17th ed.) Citation

Hassoun, Mahdi M., Ziyad R. Mahfoud, Rachid Istambouli, Ahmad M. Mansour, Haytham Salti, Souha Allam, Alaa Bou Ghannam, and Rola N. Hamam. "Intravitreal Versus Subcutaneous Adalimumab in Active Non-Infectious Uveitis: A Randomized Non-Inferiority Trial." Ocular Immunology & Inflammation 34, no. 1 (2026): 1. https://doi.org/10.1080/09273948.2025.2526692.

MLA (9th ed.) Citation

Hassoun, Mahdi M., et al. "Intravitreal Versus Subcutaneous Adalimumab in Active Non-Infectious Uveitis: A Randomized Non-Inferiority Trial." Ocular Immunology & Inflammation, vol. 34, no. 1, 2026, p. 1, https://doi.org/10.1080/09273948.2025.2526692.